Navigation Links
Allergy and Asthma Associates Selects ITelagen for Hosting and Management of EHR
Date:7/27/2010

SAN JOSE, Calif., July 27 /PRNewswire/ -- ITelagen, a leading provider of electronic health record (EHR) hosting and management announced that it was selected by Allergy and Asthma Associates of Northern California, San Jose, CA to host, support and manage EHR for their medical practice. The solution includes hosting of patient data in ITelagen's SAS-70 Type II certified datacenter and unlimited IT support for staff members.

With adoption of EHR, Allergy and Asthma Associates want to focus on delivering healthcare while leaving the information technology management to the experts. Hosting EHR remotely provides an affordable means of delivering vital patient information to caregivers, anytime and anywhere, without the need to purchase servers or hire new IT personnel. This application service provider (ASP) delivery model also speeds deployment of the technology and is becoming an increasingly important option for mid-size and independent practices.

"Our physicians want to be able to focus on the patient and providing excellent patient care, not maintaining complex IT systems," said Patricia Cunnane, Executive Director of Allergy and Asthma Associates. "We are very excited to be implementing EHR technology into our practice and happy to have ITelagen as a partner that can provide us with the secure hosting, HIPAA-compliant security and support by expert technicians."

"These are exciting times for healthcare and ITelagen is thrilled to be participating in Allergy and Asthma Associates' EHR adoption," said John O'Keefe, Chief Executive Officer of ITelagen. "Through the ease of ITelagen's ASP hosting model and our expertise in EHR, we're making it easier for mid-sized physician practices such as Allergy and Asthma Associates' to adopt EHR technology."

About ITelagen, Inc.

ITelagen® redefines Healthcare IT for medical practices by providing electronic health records (EHR) as part of an entire back-office solution, one that increases revenues, speeds collections and provides unlimited IT support for all aspects of the platform, network and staff members. It's a unique combination of comprehensive billing and IT expertise bundled with EHR, all for a flat percent of the physician's collected revenue. By combining billing, IT, hosting and certified EHR experts, ITelagen becomes the single point of contact and "One-Stop Shop for EHR®" and computing infrastructure. For more information, visit ITelagen on the Web at www.itelagen.com.

About Allergy and Asthma Associates of Northern California, San Jose, CA

We are a dedicated group of Board Certified Specialists in Adult & Pediatric Asthma, Allergy & Immunology and Pulmonary Disease. We serve on the Clinical Faculty of Stanford University School of Medicine and University of California at San Francisco (UCSF). Located throughout the greater California Bay Area, Allergy and Asthma Associates' locations in San Jose, South San Jose, Santa Cruz, Gilroy, Fremont and Mountain View offer immediate appointments, including evenings and Saturdays. For more information, visit us on the Web at www.allergycare.com.

Contact:  John O'Keefe, (201) 239-8401, press@itelagen.com


'/>"/>
SOURCE ITelagen, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T-Cell Vaccine
2. VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin
3. Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin
4. Disease and Therapy Review: Asthma Now Available at ReportsandReports
5. NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009
6. Genedata and the Institute of Experimental Medicine, Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project
7. INV102 Asthma Product Discussed at the European Respiratory Society
8. Knocking the Wind Out of Asthmatics: Help from Hippocrates
9. Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD
10. New Study Funded By the National Institutes of Health (NIH) Finds Masimo SpCO(R) May Provide a Noninvasive Measure of Acute Asthma Severity in Children
11. SiliconSky GPS Designs First AGPS-Enabled Asthma Inhaler for Landmark Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; OTCQB: ... February 24, 2017 a total of 10,672,750 common share purchase ... common share. Proceeds from the exercise of these warrants totalled ... ... are grateful for this expression of confidence by our warrant ...
(Date:2/27/2017)... YORK , February 27, 2017 ... by Stock-Callers.com for evaluation today, and they are: Anthera ... Pacific Biosciences of California Inc. (NASDAQ: PACB), and Conatus ... an article on ETF Trends, market observers are growing ... and administration could enact reforms to free cash held ...
(Date:2/27/2017)... FRANCISCO , Feb. 27, 2017 Fluxion ... Spain has been appointed as a ... System. The IsoFlux system will be used in Genetracer ... relevant to lung and colon cancer, with plans to ... The laboratory is utilizing Fluxion,s IsoFlux System to isolate, ...
(Date:2/27/2017)... ... February 27, 2017 , ... The Catalyst Midwest premix manufacturing facility ... offering premix services and private label organic services. , The first organic product is ... chief operating officer of Dynamite Marketing, which owns the facility. , Catalyst already has ...
Breaking Biology Technology:
(Date:2/7/2017)... February 7, 2017 Ipsidy Inc. ... Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a provider ... processing services, is pleased to announce the following changes ... Effective January 31, 2017, Philip D. Beck ... CEO and President.  An experienced payment industry professional and ...
(Date:2/3/2017)... ANTONIO , Feb. 3, 2017  Texas Biomedical Research ... Dr. Larry Schlesinger as the Institute,s new ... Texas Biomed effective May 31, 2017. He is currently the ... Director of the Center for Microbial Interface Biology at Ohio ... Schlesinger as the new President and CEO of Texas Biomed," ...
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
Breaking Biology News(10 mins):